EZZ Receipts Fall 38% As Cash Outflow Narrows Sharply
EZZ: $0.305 -1.61% · MC: $14M
EZZ Life Science Holdings reported customer receipts down approximately 38% year-on-year to about $7 million in Q1 FY27, reflecting softer sales across Chinese e-commerce platforms, while net operating cash outflow narrowed to about $0.4 million from more than $3 million a year earlier. EAORON skincare sales rose approximately 141% year-on-year, though the company says the brand remains a modest contributor to group revenue; potential product returns worth approximately $4 million remain under discussion with customers. EZZ ended the quarter with about $9 million in cash and no debt, excluding lease liabilities.

Comments